{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:34:47Z","timestamp":1793057687668,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:00:00Z","timestamp":1793059200000},"content-version":"vor","delay-in-days":116,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Novartis","id":[{"id":"https:\/\/ror.org\/02f9zrr09","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"DOI":"10.1038\/s41533-026-00536-z","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:07:13Z","timestamp":1783098433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Digital inhaler data in routine asthma care: defining a minimal dataset for clinical decision support (AURORA): a modified delphi study"],"prefix":"10.1038","volume":"36","author":[{"given":"Mechteld B. R.","family":"Wiertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber A.","family":"Eikholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"ten Brinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els J. M.","family":"Weersink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"van der Weerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C. C. M.","family":"in \u2019t Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelis W.","family":"Patberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Goosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels H.","family":"Chavannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Been-Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titia","family":"Klemmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib A. M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job F. M.","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"536_CR1","unstructured":"Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. (2025)."},{"key":"536_CR2","doi-asserted-by":"publisher","first-page":"175346662211169","DOI":"10.1177\/17534666221116997","volume":"16","author":"CM Averell","year":"2022","unstructured":"Averell, C. M. et al. Impact of adherence to treatment with inhaled corticosteroids\/long-acting \u03b2-agonists on asthma outcomes in the United States. Ther. Adv. Respir. Dis. 16, 17534666221116997, https:\/\/doi.org\/10.1177\/17534666221116997 (2022).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"536_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/children10040615","volume":"10","author":"RW Dal Negro","year":"2023","unstructured":"Dal Negro, R. W. & Turco, P. The extra cost due to non-adherence to inhaled treatments in adolescents with mild-to-moderate persistent asthma. Children 10, 615 (2023).","journal-title":"Children"},{"key":"536_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40273-018-0658-x","volume":"36","author":"RB McQueen","year":"2018","unstructured":"McQueen, R. B. et al. Cost-effectiveness of biological asthma treatments: a systematic review and recommendations for future economic evaluations. Pharmacoeconomics 36, 957\u2013971 (2018).","journal-title":"Pharmacoeconomics"},{"key":"536_CR5","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1016\/j.jaip.2023.06.051","volume":"11","author":"SJ van de Hei","year":"2023","unstructured":"van de Hei, S. J. et al. Long-term cost-effectiveness of digital inhaler adherence technologies in difficult-to-treat asthma. J. Allergy Clin. Immunol. Pract. 11, 3064\u20133073.e15 (2023).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"536_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.jaip.2023.12.049","volume":"12","author":"JFM van Boven","year":"2024","unstructured":"van Boven, J. F. M. et al. Cost-effectiveness and impact on health care utilization of interventions to improve medication adherence and outcomes in asthma and chronic obstructive pulmonary disease: a systematic literature review. J. Allergy Clin. Immunol. Pract. 12, 1228\u20131243 (2024).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"536_CR7","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.jaip.2025.04.039","volume":"13","author":"L Ologundudu","year":"2025","unstructured":"Ologundudu, L. et al. Patient-facing digital inhalers for asthma: a systematic review and meta-analysis. J. Allergy Clin. Immunol. Pract. 13, 1824\u20131835 (2025).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"536_CR8","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.jaip.2025.03.013","volume":"13","author":"SJ van de Hei","year":"2025","unstructured":"van de Hei, S. J. et al. Long-term effectiveness of a digital inhaler on medication adherence and clinical outcomes in adult asthma patients in primary care: the cluster randomized controlled ACCEPTANCE trial. J. Allergy Clin. Immunol. Pract. 13, 1693\u20131704 (2025).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaip.2023.11.037","volume":"12","author":"GS Mosnaim","year":"2024","unstructured":"Mosnaim, G. S. et al. Effectiveness of a maintenance and reliever digihaler system in asthma: 24-week randomized study (CONNECT2). J. Allergy Clin. Immunol. Pract. 12, 385\u2013395.e4 (2024).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"536_CR10","doi-asserted-by":"publisher","first-page":"107376","DOI":"10.1016\/j.rmed.2023.107376","volume":"218","author":"BJH Dierick","year":"2023","unstructured":"Dierick, B. J. H. et al. Electronic monitoring with a digital smart spacer to support personalized inhaler use education in patients with asthma: the randomized controlled OUTERSPACE trial. Respir. Med. 218, 107376 (2023).","journal-title":"Respir. Med."},{"key":"536_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s40521-023-00328-7","volume":"10","author":"AA Eikholt","year":"2023","unstructured":"Eikholt, A. A. et al. Electronic monitoring devices to support inhalation technique in patients with asthma: a narrative review. Curr. Treat. Options Allergy 10, 28\u201352 (2023).","journal-title":"Curr. Treat. Options Allergy"},{"key":"536_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2147\/JAA.S377631","volume":"15","author":"NL Lugogo","year":"2022","unstructured":"Lugogo, N. L. et al. A predictive machine learning tool for asthma exacerbations: results from a 12-week, open-label study using an electronic multi-dose dry powder inhaler with integrated sensors. J. Asthma Allergy 15, 1623\u20131637 (2022).","journal-title":"J. Asthma Allergy"},{"key":"536_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S2213-2600(22)00534-3","volume":"11","author":"EM Hale","year":"2023","unstructured":"Hale, E. M. et al. Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial. Lancet Respir. Med. 11, 591\u2013601 (2023).","journal-title":"Lancet Respir. Med."},{"key":"536_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41533-024-00382-x","volume":"34","author":"ML Levy","year":"2024","unstructured":"Levy, M. L. et al. Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler. NPJ Prim. Care Respir. Med. 34, 23 (2024).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"536_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4046\/trd.2024.0198","volume":"88","author":"D Larenas-Linnemann","year":"2025","unstructured":"Larenas-Linnemann, D. et al. International severe asthma registry (ISAR): 2017\u20132024 status and progress update. Tuberc. Respir. Dis. 88, 193\u2013215 (2025).","journal-title":"Tuberc. Respir. Dis."},{"key":"536_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.chest.2019.10.051","volume":"157","author":"GW Canonica","year":"2020","unstructured":"Canonica, G. W. et al. International Severe Asthma Registry. Chest 157, 805\u2013814 (2020).","journal-title":"Chest"},{"key":"536_CR17","unstructured":"European Medicines Agency. Committee for Human Medicinal Products (CHMP) Guideline on registry-based studies (Amsterdam, 2021)"},{"key":"536_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-024-02738-3","volume":"14","author":"J Schifano","year":"2025","unstructured":"Schifano, J. & Niederberger, M. How delphi studies in the health sciences find consensus: a scoping review. Syst. Rev. 14, 14 (2025).","journal-title":"Syst. Rev."},{"key":"536_CR19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jaip.2018.08.016","volume":"7","author":"L Bulathsinhala","year":"2019","unstructured":"Bulathsinhala, L. et al. Development of the international severe asthma registry (ISAR): a modified delphi study. J. Allergy Clin. Immunol. Pract. 7, 578\u2013588.e2 (2019).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"536_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2023.100800","volume":"16","author":"DES Larenas-Linnemann","year":"2023","unstructured":"Larenas-Linnemann, D. E. S. et al. Global expert views on the diagnosis, classification and pharmacotherapy of allergic rhinitis in clinical practice using a modified Delphi panel technique. World Allergy Organ. J. 16, 100800 (2023).","journal-title":"World Allergy Organ. J."},{"key":"536_CR21","unstructured":"Stichting RAPSODI RAPSODI Astma Register. (accessed 2 Feb 2026); https:\/\/rapsodiregister.nl\/."},{"key":"536_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fpubh.2020.00457","volume":"8","author":"M Niederberger","year":"2020","unstructured":"Niederberger, M. & Spranger, J. Delphi technique in health sciences: a map. Front. Public. Health 8, 457 (2020).","journal-title":"Front. Public. Health"},{"key":"536_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/JAA.S328653","volume":"15","author":"AN Menzies-Gow","year":"2022","unstructured":"Menzies-Gow, A. N. et al. Real world biologic use and switch patterns in severe asthma: data from the international severe asthma registry and the US CHRONICLE study. J. Asthma Allergy 15, 63\u201378 (2022).","journal-title":"J. Asthma Allergy"},{"key":"536_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s41030-021-00167-4","volume":"7","author":"AHY Chan","year":"2021","unstructured":"Chan, A. H. Y. et al. Digital inhalers for asthma or chronic obstructive pulmonary disease: a scientific perspective. Pulm. Ther. 7, 345\u2013376 (2021).","journal-title":"Pulm. Ther."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00536-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00536-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00536-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:25:04Z","timestamp":1793057104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00536-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1038\/s41533-026-00536-z","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.F.M.v.B. received a research grant from Novartis paid to his institution for the study and reports grants and\/or consultancy fees from ALK-Abello, AstraZeneca, Chiesi, European Commission COST (COST Action 19132), GSK, Novartis, Sanofi, Teva, Trudell Medical, and Vertex, outside the submitted work and all paid to his institution.J.i.V. received unrestricted research grants from AstraZeneca, Chiesi, GSK, Sanofi, Teva, paid to his institution for the study, and reports consultancy speaker fees from AstraZeneca, Chiesi, GSK, Sanofi, Teva outside the submitted work.A.t.B. received unrestricted research grants from AstraZeneca, GSK, and Teva, and reports consultancy fees from AstraZeneca, GSK, SanofiGenzyme, and Celltrion, and speaker fees from AstraZeneca, GSK, and SanofiGenzyme outside the submitted work.H.A.M.K. received unrestricted research grants and\/or consultancy fees for advisory boards from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Novartis, Sanofi, Teva, all paid to its institutionE.W. has received advisory board and speaker fees from GlaxoSmithKline, AstraZeneca, and Sanofi; conference support from AstraZeneca and Sanofi; and grant funding to her institution from AstraZeneca. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"71"}}